Actively Recruiting
Improving Language Abilities in Adults with Aphasia Using Personalized Speech Therapy
Led by University of Arizona · Updated on 2024-12-09
30
Participants Needed
1
Research Sites
76 weeks
Total Duration
AI-Summary
What this Trial Is About
Aphasia is a language impairment often caused by brain damage, affecting understanding, speaking, reading, and writing. This study aims to develop and evaluate a semantic-based language treatment for individuals with acquired language disorders such as aphasia, including those caused by stroke or dementia and primary progressive aphasia. Researchers want to understand both the treatments impact on language abilities and the related brain activity changes over time. Participants will receive individualized language therapy focused on semantic or phonological strategies to improve word finding, sentence formation, and storytelling abilities. The treatment is tailored to each participants language and cognitive level, based on baseline testing. Sessions occur twice weekly for 10 weeks. A control group will receive standard speech-language intervention for comparison. Participants will undergo assessments before treatment, immediately after, and two months post-treatment. These include cognitive and language tests, electroencephalography EEG recordings, and magnetic resonance imaging MRI scans to monitor brain activity and language improvements. The study measures changes in naming ability, aphasia severity, and language task performance over about one year. This comprehensive evaluation will help understand both short- and long-term effects of the treatments.
CONDITIONS
Brief Title
Enhancing Language Function in Aphasia
Research Team
A
Aneta Kielar, PhD
F
Fatima Jebahi, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here